| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABBOTT LABORATORIES | EVP AND GROUP PRESIDENT | Common shares without par value | 71,928 | $9,828,602 | $136.64 | 07 Mar 2025 | Direct |
| ABBOTT LABORATORIES | EVP AND GROUP PRESIDENT | Common shares without par value | 61,462 | $6,530,589 | $106.25 | 07 May 2024 | Direct |
| ABBOTT LABORATORIES | EVP AND GROUP PRESIDENT | Option (right to buy) | 0 | 07 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 06 Mar 2025 | 6 | -$4,828,397 | 4 | EVP AND GROUP PRESIDENT | 07 Mar 2025, 18:55 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2025 | 1 | -$1,130,710 | 4 | EVP AND GROUP PRESIDENT | 04 Mar 2025, 19:27 |
| ABT | ABBOTT LABORATORIES | 25 Feb 2025 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 27 Feb 2025, 17:58 |
| ABT | ABBOTT LABORATORIES | 07 May 2024 | 1 | -$2,428,119 | 4 | EXECUTIVE VICE PRESIDENT | 08 May 2024, 17:00 |
| ABT | ABBOTT LABORATORIES | 29 Feb 2024 | 2 | -$1,002,902 | 4 | EXECUTIVE VICE PRESIDENT | 04 Mar 2024, 18:50 |
| ABT | ABBOTT LABORATORIES | 21 Feb 2024 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 23 Feb 2024, 17:33 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2023 | 2 | -$856,305 | 4 | EXECUTIVE VICE PRESIDENT | 02 Mar 2023, 18:27 |
| ABT | ABBOTT LABORATORIES | 17 Feb 2023 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 22 Feb 2023, 17:48 |
| ABT | ABBOTT LABORATORIES | 10 Jun 2022 | 2 | -$2,533,045 | 4 | EXECUTIVE VICE PRESIDENT | 14 Jun 2022, 17:18 |
| ABT | ABBOTT LABORATORIES | 28 Feb 2022 | 2 | -$744,031 | 4 | EXECUTIVE VICE PRESIDENT | 02 Mar 2022, 18:38 |
| ABT | ABBOTT LABORATORIES | 18 Feb 2022 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 23 Feb 2022, 19:07 |
| ABT | ABBOTT LABORATORIES | 10 Jun 2021 | 1 | -$314,173 | 4 | EXECUTIVE VICE PRESIDENT | 11 Jun 2021, 17:09 |